Approval · Notice of Compliance 35605 · 2025
CONTINGENCY ONE: Notice of Compliance 35605
Issued June 30, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35605
- Date
- June 30, 2025
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with supporting PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONTINGENCY ONE | 02425009 | Marketed |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB